ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

191
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
03 May 2020 16:56

HK Connect Weekly: Tencent, Ping An Good Dr, Sino Biopharm, SMIC, CSPC, Sunny Optical

In our weekly HK Connect Flow series, we aim to highlight key stocks and sectors which the mainland investors traded via the southbound  Hong Kong...

Logo
249 Views
Share
27 Apr 2020 15:59

HK Connect Weekly: Tencent, Sino Biopharm, CSPC, SMIC

In our weekly HK Connect Flow series, we aim to highlight key stocks and sectors which the mainland investors traded via the southbound  Hong Kong...

Logo
267 Views
Share
bullishKingsoft Cloud
26 Apr 2020 12:44

ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Akeso...

Share
21 Apr 2020 21:49

Hansoh Pharma Placement - Good Stock but Valuation and No Lack of Cash Makes It Appear Opportunistic

Hansoh Pharmaceutical (3692 HK) aims to raise up to US$450m to funds its R&D and general working capital requirements. The company was listed...

Logo
398 Views
Share
20 Apr 2020 20:39

Sino Biopharm (中国生物制药) Placement - Not a Big Deal, Still a Good Company but Relatively Expensive

A shareholder of Sino Biopharmaceutical (1177 HK) is looking to sell about US$297m worth of shares in an accelerated block trade.In this note, we...

Share
x